Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-05-19 @ 12:59 PM
Study NCT ID:
NCT00453102
Status:
COMPLETED
Last Update Posted:
2016-01-01
First Post:
2007-03-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
Sponsor:
University of Miami
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20060078
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None